Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection - Archive ouverte HAL
Article Dans Une Revue eLife Année : 2022

Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection

Résumé

The definition of correlates of protection is critical for the development of next generation SARS-CoV-2 vaccine platforms. Here, we propose a new framework for identifying mechanistic correlates of protection based on mathematical modelling of viral dynamics and data mining of immunological markers. The application to three different studies in non-human primates evaluating SARS-CoV-2 vaccines based on CD40-targeting, two-component spike nanoparticle and mRNA 1273 identifies and quantifies two main mechanisms that are a decrease of rate of cell infection and an increase in clearance of infected cells. Inhibition of RBD binding to ACE2 appears to be a robust mechanistic correlate of protection across the three vaccine platforms although not capturing the whole biological vaccine effect. The model shows that RBD/ACE2 binding inhibition represents a strong mechanism of protection which required significant reduction in blocking potency to effectively compromise the control of viral replication.
Fichier principal
Vignette du fichier
elife-75427-v2.pdf (3.44 Mo) Télécharger le fichier
Origine Fichiers éditeurs autorisés sur une archive ouverte
Licence

Dates et versions

hal-03482728 , version 1 (16-12-2021)
hal-03482728 , version 2 (18-01-2023)

Licence

Identifiants

Citer

Marie Alexandre, Romain Marlin, Mélanie Prague, Séverin Coleon, Nidhal Kahlaoui, et al.. Modelling the response to vaccine in non-human primates to define SARS-CoV-2 mechanistic correlates of protection. eLife, 2022, 11, pp.e75427. ⟨10.7554/eLife.75427⟩. ⟨hal-03482728v2⟩
220 Consultations
171 Téléchargements

Altmetric

Partager

More